CCM
Concord Medical Services Holdings·NYSE
--
--(--)
--
--(--)
2.16 / 10
Underperform
The company shows concerning fundamentals (2.2/10). Positive drivers: Net profit attributable to parent company shareholders / Net profit (%) and Interest coverage ratio (EBIT / Interest expense) (%), offset by weaknesses in Net profit / Total profit (%). This supports a constrained investment view.
Analysis Checks(4/5)
ROA (%)
Value-3.05
Score2/3
Weight5.60%
1M Return-0.39%
Value-3.05
Score2/3
Weight5.60%
1M Return-0.39%
Annualized net profit margin on total assets (%)
Value-6.10
Score2/3
Weight5.60%
1M Return-0.39%
Value-6.10
Score2/3
Weight5.60%
1M Return-0.39%
Net profit / Total profit (%)
Value110.66
Score1/3
Weight37.14%
1M Return-2.89%
Value110.66
Score1/3
Weight37.14%
1M Return-2.89%
Net profit attributable to parent company shareholders / Net profit (%)
Value13.21
Score2/3
Weight24.29%
1M Return-1.71%
Value13.21
Score2/3
Weight24.29%
1M Return-1.71%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight27.38%
1M Return-1.95%
Value27.58
Score2/3
Weight27.38%
1M Return-1.95%
ROA (%)
Value-3.05
Score2/3
Weight5.60%
1M Return-0.39%
Value-3.05
Score2/3
Weight5.60%
1M Return-0.39%
Net profit attributable to parent company shareholders / Net profit (%)
Value13.21
Score2/3
Weight24.29%
1M Return-1.71%
Value13.21
Score2/3
Weight24.29%
1M Return-1.71%
Annualized net profit margin on total assets (%)
Value-6.10
Score2/3
Weight5.60%
1M Return-0.39%
Value-6.10
Score2/3
Weight5.60%
1M Return-0.39%
Interest coverage ratio (EBIT / Interest expense) (%)
Value27.58
Score2/3
Weight27.38%
1M Return-1.95%
Value27.58
Score2/3
Weight27.38%
1M Return-1.95%
Net profit / Total profit (%)
Value110.66
Score1/3
Weight37.14%
1M Return-2.89%
Value110.66
Score1/3
Weight37.14%
1M Return-2.89%
Is CCM fundamentally strong?
- CCM scores 2.16/10 on fundamentals and holds a Premium valuation at present. Backed by its -1.62% ROE, -144.11% net margin, -0.84 P/E ratio, 0.08 P/B ratio, and 57.76% earnings growth, these metrics solidify its Underperform investment rating.
